Clinical trialNCT06312722RecruitingInterventional

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

SponsorUrotronic Inc.Enrollment92Benign Prostatic Hyperplasia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Steven Kaplan, MD, FACS
Professor of Urology
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Arkansas Urology
Little Rock, Arkansas, United States
Jeffrey Marotte, MD
Recruiting
Florida Urology Partners, Llp
Tampa, Florida, United States
Osvaldo Padron, MD
Recruiting
Ochsner Lsu Health Shreveport - Regional Urology
Shreveport, Louisiana, United States
Jared Moss, MD
Recruiting
Sheldon Freedman Md, Ltd
Las Vegas, Nevada, United States
Sheldon Freedman, MD
Recruiting
Oregon Urology Institute
Springfield, Oregon, United States
David DiMarco, MD
Recruiting
Midtown Urology Associates
Austin, Texas, United States
Michael Trotter, MD
Recruiting
Houston Methodist Urology Associates
Houston, Texas, United States
Ricardo Gonzalez, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Feb 2024
Primary completion: 7 Feb 2031
Completion: 7 Feb 2031
Last update posted: 10 Jul 2026
Registered enrollment: 92
Registry id: NCT06312722

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.